Neomycin sulphateis an aminoglycoside antibiotic. The product has good antibacterial effect on enterobacteriaceae bacteria such as Staphylococcus (methicillin sensitive strain), Corynebacterium, Escherichia coli, Klebsiella, Proteus, etc., but has poor activity against streptococcus, Streptococcus pneumoniae, Enterococcus, etc. in each group. Pseudomonas aeruginosa and anaerobes are resistant to this product. The bacteria have partial or complete cross-resistance to streptomycin, neomycin, kanamycin and gentamicin. The systemic use of neomycin has significant nephrotoxicity and ototoxicity, so it is only limited to oral or local use.
Company Profile
ARTHA Group
The manufacturer and developer of high quality medicine and APIs that benefit human health.
VERSION ARTHA group is the manufacturer and developer of high quality medicine and APIs that benefit human health, we are committed to supplying quality products for using in the pharmaceutical, healthcare and veterinary industries.
MISSION ARTHA groupto create more value for our clients, to provide a comprehensive range of customized value-added services and products and to meet each client's specific requirements.
Main products:
API ; Drug Impurity; Infusion: Injection; Tablets; Capsule; Solution(Lotion); Suppositories